List of Tables
Table 1. Gastric Carcinomas Drugs Market Trends
Table 2. Gastric Carcinomas Drugs Market Drivers & Opportunity
Table 3. Gastric Carcinomas Drugs Market Challenges
Table 4. Gastric Carcinomas Drugs Market Restraints
Table 5. Global Gastric Carcinomas Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Gastric Carcinomas Drugs Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Gastric Carcinomas Drugs Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Gastric Carcinomas Drugs Product Type
Table 9. Key Companies Time to Begin Mass Production of Gastric Carcinomas Drugs
Table 10. Global Gastric Carcinomas Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastric Carcinomas Drugs as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Gastric Carcinomas Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Gastric Carcinomas Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Gastric Carcinomas Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Gastric Carcinomas Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Gastric Carcinomas Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Gastric Carcinomas Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Gastric Carcinomas Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Gastric Carcinomas Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Gastric Carcinomas Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Gastric Carcinomas Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Gastric Carcinomas Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Gastric Carcinomas Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Gastric Carcinomas Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Gastric Carcinomas Drugs Sales Value by Region (2019-2024) & (%)
Table 27. Global Gastric Carcinomas Drugs Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Gastric Carcinomas Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Gastric Carcinomas Drugs Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Gastric Carcinomas Drugs Sales Value, (2025-2030) & (US$ Million)
Table 31. Pfizer Basic Information List
Table 32. Pfizer Description and Business Overview
Table 33. Pfizer Gastric Carcinomas Drugs Products, Services and Solutions
Table 34. Revenue (US$ Million) in Gastric Carcinomas Drugs Business of Pfizer (2019-2024)
Table 35. Pfizer Recent Developments
Table 36. Novo Nordisk Basic Information List
Table 37. Novo Nordisk Description and Business Overview
Table 38. Novo Nordisk Gastric Carcinomas Drugs Products, Services and Solutions
Table 39. Revenue (US$ Million) in Gastric Carcinomas Drugs Business of Novo Nordisk (2019-2024)
Table 40. Novo Nordisk Recent Developments
Table 41. Bayer Basic Information List
Table 42. Bayer Description and Business Overview
Table 43. Bayer Gastric Carcinomas Drugs Products, Services and Solutions
Table 44. Revenue (US$ Million) in Gastric Carcinomas Drugs Business of Bayer (2019-2024)
Table 45. Bayer Recent Developments
Table 46. Merck & Co Basic Information List
Table 47. Merck & Co Description and Business Overview
Table 48. Merck & Co Gastric Carcinomas Drugs Products, Services and Solutions
Table 49. Revenue (US$ Million) in Gastric Carcinomas Drugs Business of Merck & Co (2019-2024)
Table 50. Merck & Co Recent Developments
Table 51. Roche Basic Information List
Table 52. Roche Description and Business Overview
Table 53. Roche Gastric Carcinomas Drugs Products, Services and Solutions
Table 54. Revenue (US$ Million) in Gastric Carcinomas Drugs Business of Roche (2019-2024)
Table 55. Roche Recent Developments
Table 56. Eli Lilly and Company Basic Information List
Table 57. Eli Lilly and Company Description and Business Overview
Table 58. Eli Lilly and Company Gastric Carcinomas Drugs Products, Services and Solutions
Table 59. Revenue (US$ Million) in Gastric Carcinomas Drugs Business of Eli Lilly and Company (2019-2024)
Table 60. Eli Lilly and Company Recent Developments
Table 61. Taiho Pharmaceutical Basic Information List
Table 62. Taiho Pharmaceutical Description and Business Overview
Table 63. Taiho Pharmaceutical Gastric Carcinomas Drugs Products, Services and Solutions
Table 64. Revenue (US$ Million) in Gastric Carcinomas Drugs Business of Taiho Pharmaceutical (2019-2024)
Table 65. Taiho Pharmaceutical Recent Developments
Table 66. Jiangsu Hengrui Medicine Company Limited Basic Information List
Table 67. Jiangsu Hengrui Medicine Company Limited Description and Business Overview
Table 68. Jiangsu Hengrui Medicine Company Limited Gastric Carcinomas Drugs Products, Services and Solutions
Table 69. Revenue (US$ Million) in Gastric Carcinomas Drugs Business of Jiangsu Hengrui Medicine Company Limited (2019-2024)
Table 70. Jiangsu Hengrui Medicine Company Limited Recent Developments
Table 71. Fujian Haiwang Fuyao Pharmacy Limited Company Basic Information List
Table 72. Fujian Haiwang Fuyao Pharmacy Limited Company Description and Business Overview
Table 73. Fujian Haiwang Fuyao Pharmacy Limited Company Gastric Carcinomas Drugs Products, Services and Solutions
Table 74. Revenue (US$ Million) in Gastric Carcinomas Drugs Business of Fujian Haiwang Fuyao Pharmacy Limited Company (2019-2024)
Table 75. Fujian Haiwang Fuyao Pharmacy Limited Company Recent Developments
Table 76. Qilu Pharma Basic Information List
Table 77. Qilu Pharma Description and Business Overview
Table 78. Qilu Pharma Gastric Carcinomas Drugs Products, Services and Solutions
Table 79. Revenue (US$ Million) in Gastric Carcinomas Drugs Business of Qilu Pharma (2019-2024)
Table 80. Qilu Pharma Recent Developments
Table 81. Shandong New Era Hotel Pharmaceutical Industry Limited Company Basic Information List
Table 82. Shandong New Era Hotel Pharmaceutical Industry Limited Company Description and Business Overview
Table 83. Shandong New Era Hotel Pharmaceutical Industry Limited Company Gastric Carcinomas Drugs Products, Services and Solutions
Table 84. Revenue (US$ Million) in Gastric Carcinomas Drugs Business of Shandong New Era Hotel Pharmaceutical Industry Limited Company (2019-2024)
Table 85. Shandong New Era Hotel Pharmaceutical Industry Limited Company Recent Developments
Table 86. Chiatai Tianqing Basic Information List
Table 87. Chiatai Tianqing Description and Business Overview
Table 88. Chiatai Tianqing Gastric Carcinomas Drugs Products, Services and Solutions
Table 89. Revenue (US$ Million) in Gastric Carcinomas Drugs Business of Chiatai Tianqing (2019-2024)
Table 90. Chiatai Tianqing Recent Developments
Table 91. Key Raw Materials Lists
Table 92. Raw Materials Key Suppliers Lists
Table 93. Gastric Carcinomas Drugs Downstream Customers
Table 94. Gastric Carcinomas Drugs Distributors List
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Gastric Carcinomas Drugs Product Picture
Figure 2. Global Gastric Carcinomas Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Gastric Carcinomas Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Gastric Carcinomas Drugs Report Years Considered
Figure 5. Global Gastric Carcinomas Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Gastric Carcinomas Drugs Revenue in 2023
Figure 7. Gastric Carcinomas Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. First Line Treatment Picture
Figure 9. Second Line Treatment Picture
Figure 10. Three Line Treatment Picture
Figure 11. Global Gastric Carcinomas Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Gastric Carcinomas Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Hospital
Figure 14. Product Picture of Clinic
Figure 15. Product Picture of Others
Figure 16. Global Gastric Carcinomas Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Gastric Carcinomas Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Gastric Carcinomas Drugs Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Gastric Carcinomas Drugs Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Gastric Carcinomas Drugs Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Gastric Carcinomas Drugs Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Gastric Carcinomas Drugs Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Gastric Carcinomas Drugs Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Gastric Carcinomas Drugs Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Gastric Carcinomas Drugs Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Gastric Carcinomas Drugs Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Gastric Carcinomas Drugs Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Gastric Carcinomas Drugs Sales Value (%), (2019-2030)
Figure 29. United States Gastric Carcinomas Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Gastric Carcinomas Drugs Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Gastric Carcinomas Drugs Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Gastric Carcinomas Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Gastric Carcinomas Drugs Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Gastric Carcinomas Drugs Sales Value by Application (%), 2023 VS 2030
Figure 35. China Gastric Carcinomas Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Gastric Carcinomas Drugs Sales Value by Type (%), 2023 VS 2030
Figure 37. China Gastric Carcinomas Drugs Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Gastric Carcinomas Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Gastric Carcinomas Drugs Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Gastric Carcinomas Drugs Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Gastric Carcinomas Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Gastric Carcinomas Drugs Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Gastric Carcinomas Drugs Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Gastric Carcinomas Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Gastric Carcinomas Drugs Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Gastric Carcinomas Drugs Sales Value by Application (%), 2023 VS 2030
Figure 47. India Gastric Carcinomas Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Gastric Carcinomas Drugs Sales Value by Type (%), 2023 VS 2030
Figure 49. India Gastric Carcinomas Drugs Sales Value by Application (%), 2023 VS 2030
Figure 50. Gastric Carcinomas Drugs Industrial Chain
Figure 51. Gastric Carcinomas Drugs Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
